Clinical Trial Results:
Study of the effects of telomerase reactivation with Danazol on ovarian function. A Pilot Study.
Summary
|
|
EudraCT number |
2018-004400-19 |
Trial protocol |
ES |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v3(current) |
This version publication date |
12 Oct 2023
|
First version publication date |
11 Oct 2022
|
Other versions |
v1 , v2 |
Version creation reason |
|
Summary report(s) |
Letter-Premature_ending_Of__CT Danazol paper Final Document |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.